Drug Profile
Octreotide depot - GP Pharm
Alternative Names: Minoctre; Octreotide LAR; Octreotide MARLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator GP Pharm
- Class Antidiarrhoeals; Antineoplastics; Antisecretories; Cyclic peptides; Eye disorder therapies; Indoles; Somatostatins
- Mechanism of Action Growth hormone-releasing hormone inhibitors; Somatostatin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acromegaly; Carcinoid tumour; Diarrhoea
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for phase-I development in Diarrhoea(Chemotherapy-induced) in Spain (IM, Controlled release)
- 28 Feb 2019 No recent reports of development identified for phase-I development in Acromegaly in Spain (IM, Controlled release)
- 28 Feb 2019 No recent reports of development identified for phase-I development in Carcinoid tumour in Spain (IM, Controlled release)